AI & Predictive Modeling Are Transforming HEOR

For years, HEOR teams have focused on describing the past: analyzing retrospective claims, EMR data, and trial endpoints to understand treatment patterns and cost trajectories. But the next competitive edge in market access won’t come from explaining what happened. It...

From Insight to Action: Why Many Teams Stall at the Last Mile

Gathering insight is one thing. Acting on it fast enough to matter? That’s the real differentiator. Across pharma and biotech, manufacturers invest heavily in market access research—payer interviews, advisory panels, and data dashboards that reveal how coverage...